Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 34Terminated 6Recruiting 5Active not recruiting 5Withdrawn 3Unknown 2

Sponsor Class

OTHER 83INDUSTRY 10NETWORK 5NIH 3OTHER_GOV 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 18Prostatic Neoplasms 15Neoplasms 12Multiple Myeloma 11Carcinoma, Non-Small-Cell Lung 11Melanoma 9Pancreatic Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lung Neoplasms 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Sarcoma 4Ovarian Neoplasms 4Osteosarcoma 4Hematologic Neoplasms 4Brain Neoplasms 4Teratoma 3Smoldering Multiple Myeloma 3Small Cell Lung Carcinoma 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Neoplasm Metastasis 3Malignant Solid Neoplasm 3HIV Infections 3Fallopian Tube Neoplasms 3Colonic Neoplasms 3

Interventions

pembrolizumab 1Specimen Handling 1Nivolumab 1Gemcitabine 1Dexamethasone 1Cisplatin 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Hodgkin Disease × Clear all
NCT06002828 2026-05-06

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Eastern Cooperative Oncology Group

Recruiting
2,000 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT01351545 2026-04-13

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Center for International Blood and Marrow Transplant Research

Recruiting
99,999 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Autoimmune Diseases, Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05180097 2026-02-02

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Canadian Cancer Trials Group

Phase 2 Recruiting
84 enrolled
Lymphoid

Hodgkin Disease

NCT07209059 2025-10-06

FINISH-HL

National Research Center for Hematology, Russia

Phase 2 Recruiting
30 enrolled
Lymphoid

Hodgkin Disease

NCT06263530 2024-02-16

Prognostic Significance of ctDNA in HL

Interni hematologicka klinika FNKV

Recruiting
500 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡